CONFERENCES PRESENTATIONS



1.Ehrlich Y. et al. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer. Is there a place for a limited lymph node dissection? Israeli Urological Association Meeting, Eilat, Israel 2003.



2.Ehrlich Y. et al. Characteristics of bacterial colonization of ureteral double-J stents in children. Israeli Urological Association Meeting, Eilat, Israel 2003.



3.Ehrlich Y. et al. High incidence of metabolic disturbances among calcium-oxalate and calcium-phosphate stone formers. Israeli Urological Association Meeting, Eilat, Israel 2003.



4.Ehrlich Y. et al. Reversible acute renal failure after relive of unilateral ureteral obstruction in the presence of normal contralateral kidney. Israeli Urological Association Meeting, Eilat, Israel 2005.



5.Ehrlich Y. et al. Benign testicular masses in radical orchiectoy. Israeli Urological Association Meeting, Eilat, Israel 2005.



6.Ehrlich Y. et al. High incidence of postoperative morbidity after ureteroneocystostomy performed before the first year of life. Israeli Urological Association Meeting, Eilat, Israel 2005.



7.Ehrlich Y. et al. The delay in treating testicular germ cell tumors does not increase the risk of clinical stage progression. Israeli Urological Association Meeting, Eilat, Israel 2006.



8.Ehrlich Y. et al. Timing of aspirin reinstitution after prostate and transurethral bladder surgeries - Impact on development of potoperative bleeding. A prospective clinical trial. Israeli Urological Association Meeting, Eilat, Israel 2006.



9.Ehrlich Y. et al. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding - a prospective randomized trial. AUA Annual Meeting in Anaheim CA 2007.



10.Ehrlich Y, Konichezky M, Yossepowitch O, Baniel J. Concomitant microscopic tumor deposits accompanying overt testicular cancer. AUA Annual Meeting in Orlando FL 2008.



11.Ehrlich Y, Beck SD, Bihrle R, Donohue JP, Foster RS. Does the duration of symptoms before orchiectomy predict metastatic disease in patients presenting with clinical stage A nonseminomatous germ cell tumor. AUA Annual Meeting in Orlando FL 2008.



12.Ehrlich Y, Brames MJ, Beck SD, Foster RS, Einhorn LH. Long-term follow-up of chemotherapy-induced remissions in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 27:15s, 2009 (suppl; abstr 5029) ASCO 2009.



13.Foster RS, Ehrlich Y, Ulbright TM, Cheng L, Bihrle R, Beck SD, Andreoiu M, Brames MJ, Einhorn LH. Malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): Outcome analysis with retroperitoneal lymph node dissection and PNET specific chemotherapy. J Clin Oncol 27:15s, 2009 (suppl; abstr 5081) ASCO 2009.



14.Brames MJ, Ehrlich Y, Einhorn LH. Malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): Outcome analysis with PNET based chemotherapy. J Clin Oncol 27, 2009 (suppl; abstr e16121) ASCO 2009.



15.Ehrlich Y, Barlass L, Masters J. The Auckland retropubic radical prostatectomy experience 2002-2010. New Zealand Section Meeting 2011.